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I.

INTRODUCTION

In the early l 930's a research team investigated food poisonings whi~h
occurred among the natives of central Java and found that "bongkrek,"

a coconut

product made by the natives, appeared to be toxic when contaminated by an aerobic
bacterium, Pseudomonas cocovenenans (1). Two toxic substances were isolated from a
culture of the bacterium on the_ coconut product;

hongkrekic acid (2) and toxoflavin.

The structure of toxoflavin was investigated by several researchers (3,4,5,6) and was
finally established by X-ray. The total synthesis of toxoflavi:r; (7) confirmed the structure
prniously

established_

The synthesized compo~md was foirnd to be identical to the

natural product.

Toxoflavin

Fervenulin

Fervenulin, an antibiotic isolated from culture filtrates of an aetinomycete,
(8), Strcptomyces fervens, was found to be an isomer of toxoflavin with antibacterial,
antifungal, antiparasitic and antitumor cell activity in vitro.
An antibiotic, called xanthothricin, was isolated from a culture of a member

of the genus Streptomyces.
Studies of

It was found to be very toxic and identical ·with toxoflavin.

ttw toxicity of toxofJavin led to the conclusion that the formation of hydrogen

peroxide was responsible for the toxicil ): of toxoflavin.
Due to the fact that toxoflavin has antibiotic properties but is too toxic to
Le med on humans, it is proposed to synthesize analogs of toxoflavin anrl fervem1lin

2

by replacing the nitrogen atom at position 4 and positions 2 and 4 on the triazine ring
with a carbon atom.

By so doing, it is hoped that the antimetabolite characteristics

may be retained and the toxicity to hilmMis decreased. It is known that sometimes a
small change in the structure of a compound can modify some of its properties.
Analogs containing the pyrimido [4,5-c] pyridazine ring system, which has only
recently been investigated (since 1958), and the pyrido[2,3-d]pyrimidine

ring syste_m,

which has been studied more intensively (since 1923), were both considered.
The main intermediate from which the compounds were prepared was 6-chloro3-methyluracil (X) obtained by the method of Daves, Robins and Cheng (7) .. Some inter-

•

mediates will be synthesized by replacing the chlorine atom of 6-chloro-3-methyluracil by
methylhydrazine, hydrazine and phenylhydrazine, respectively. Some analogs of toxo,

/

flavin have already been synthesized (21):

4-deazatoxoflavin (XXV) and l-benzyl-4-

deazatoxoflavin (XXVI). 4-Deazafervenulin has already been prepared by Pfleiderer and
Ferch (19) by a method which was used in the preparation of the analogs of toxoflavin
and f ervenulin.
The proposed cyclized compounds containing the pyrimido[ 4,5-c] pyridazine
ring system are the following:

I ,3,4,6-tetramethyl-t5,6,

7-tetrahydropyrimido[ 4,5-c ]-

5, 7-pyri<lazinedione (XXX VII);

l,6-dimethyl-3,4-diphenyl-l,5,6, 7-tetrahydropyrimido-

[4,5-c]-5,7-pyridazinedione (XXXVIII); 3,4,6-trimethyl-5,6,
7,8-t etrah ydro pyri
mido .~
.
;

[4,5-c]-5,7-pyridazinedione (XL); and 6-methyl-3,4-diphenyI-5;6, 7,8-tetrahydropyrimido[4,5-c ]-5,7-pyridazinedione.
Several intermediates were synthesized by replacing the chlorine atom of
6-chloro-3-methyluracil at position 6 with methylamine, n-propylamine, n-butylamine,
aniline· and benzylamine respectively.
The proposed cyclized compounds containing the pyrido[ 2,3-d] pyrimidine ring
system are the following: 3,5,6-trimethyl-8-phenyl-2,3,4,8-tetrahydropyrido[

2,3-d]-5, 7-

P)'.rimidinedione (L V) and 2-hydroxy-3,5, 7-trimethyl-4(3H)pyrido [ 2,3-d] pyr~midinone
(LVII).

It was proposed to prepare 3-ethyl-2-ethylthio-6-hydroxy-4(3H)pyrimi<linone
(L VIII) by the reaction of 2-thiop~~bituric acid an_d.diethyls~dfate 'in the presence of
sodium hydroxide according to the method of ~aves, Robins and Clieng' (7).

. II.

..

,

REVIEW OF LITERATURE

Isolation of Toxoflavin

In 1933, a bacterium called Pseudomonas cocovenenans was discovered by
rnn Veen and Mertens, as being responsible for the fatal food poisonings occurring
among the natives in the densely populated parts of central Java (1).

They showed

that "bongkrek", a popular food made by the natives, could sometimes he very toxic.
"Bongkrek" is a coconut product which is prepared from finely divided copra· (dried
coconut meat yielding coconut oil) after the oil has been expressed. The residue from
'

this copra after inoculation with a mold is incubated.
"bongkrek"

<

The occasional toxicity of

appeared to be caused by contamination. of the product by an aerobic

bacterium, later named Pseudomonas cocovenenans.
~

1

It was postulated that the poisonings 9ccurred .because the growth of the
harmless Rhizopus fungi in-"bongkrek" was inhibited ...allowing an opportunity for other
orga~isms to grow, among them was Pseudomonas cocovenenans. van

yeen and Mertens

( l) found that a large aqueous surface exposed to air ("bongkrek"

is made from

grated coconut) favored the formation of the toxic agent, .Pseudomonas cocovenenans. ·
The latter excretes two antibiotic substances which inhibit any fungus growth that
takes place. Later van Veen was able to show that at least one of the substances causing
the poisoning in man is also a strong antibiotic for the Rhizopus fungi.

Two toxic

substances have hcen isolated from a culture of the bacteriu~n on copra.
One of these, bongkrekic acid, was isolated by van Veen et al. and purified
by i\'ugteren and Berends (2). This is a highly unsaturated and very labile fatty

with the composition C2 9 H4 0 0 7 • Only part of its structure was eluci~ated.

acid

The other

' Pseudomonas
toxic substance, toxoflavin, is identical with the yellow. pigment from
cocovenenans.

The compound was difficult to isolate and finally, when cultures were ·

grown on filter paper, the toxic substance was obtained in pure form.
3

Starting with

't

4,

.

200. ml. of a 1% glycerol solution which contained 0.5% peptone and the _necessary nutrient salts, van Veen and l\Iertens (1) obtained a deep yellow liquid over a period
of forty hours. The liquid was cooled with ice water, saturated with anhydrous sodium
sulfate and extracted

with chloroform.

Extraction

of the substance with water,

petroleum ether and ethyl acetate gave a deep yellow liquid which had a dry weight
of )0-20 mg. and was sufficient to kill 300-700 rats. When isolated in crystalline form,
the substance was yellow needles which melted at 200°. The very intense yellow color
was observed even in very dilute solutions (1:200,000).

When crystallized from warm

benzene, the substance became partially oily and it was very difficult to obtain the
compound pure enough for analysis.

It had a high nitrogen content; exhibited no

alkaloid reactions, had an amphoteric character and was easy to dialyze.

Determination of the Structure of Toxoflavin
The elucidation of the structure of toxoflavin was attempted by van Veen
and Baars (3). Their conclusions as to the structure were very improbable.

Their work

can be summarized as follows:

1. Analysis and determination of the molecular weight by the Rast ri1ethod
'

•'

/

led them to the empirical formula C6 H 6 N4 0 2 :
2.

With o-phenylenediamine in slightly acid solution, toxoflavin yielded a

compound C1 1 Ha N4 0 2

,

which was shown to be N-methylalloxazine.

From this,

they concluded that toxoflavii-i should contain the N-methylalloxan ring, I. ·
3.

Toxoflavin. could be easily reduced but· showed relatively great stability

towards oxidants, therefore side-chains should be absent.
4.
was obtained.

On treatment of toxoflavin with mineral acid,, a compound C6 Ha N403
I

,.,

This was considered to Le a hydrate of toxoflavin II.

Combining these results, van Veen and Baars (3) proposed the structure III
for toxoflavin, which differed from methylxa~thine
double bonds.

IV only_ in the positions of the

,,

5
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Figure 1. Structure Elucidation of Toxoflavin
It would be expected that isomerization of the proposed structure (III) of toxoflavin to 3-methylxanthine would occur easily. Several attempts were made but were not
successful. Furthermore, the chemical and physical properties of 1-methylxanthine were
found to he' very different from those of toxoflavin.
Reconsideration of van Veen's conclusions brought Nugteren to the statement
that the structure (III) proposed for toxoflavin could not be correct (4). Van Damme,

et al. (5) found that the analyses of toxoflavin described by van Veen and Baars ~er,e
incorrect.

The empirical formula for toxoflavi?

C6 H6 N4 0 2

•

should be C7 H 7 N 5 0 2

and not

They redetermined the molecular weight by using the Signer's isothermal

distillation method and the result ,~as in complete agreement with the n~wly proposed
formula.

'

They repeated the reaction of toxo_flavin in aqueous solution with o-phenyl-

enediamine dihydrochloride and obtair:,ed. the same results as van Veen et al., that is
N-mcthylalloxazine (C 1 1 H8 N4 Oi ). Therefore, toxoflavin had to contain a disubstituted
N-methylpyrimidine ring system.

,-

6

y

JZI
:Figure 2. Possible Structures for Toxoflavin

Two possible structures were proposed for"•toxoflavin Y and VI. . Finally
the structure of toxoflavin was established by X-ray (6) ancl was found to be structure VI.
The total synthesis of toxoflavin accomplished by Daves, ,Robins and Cheng (7)
confirmed the structure VI assigned by van Damme et al. in every respect: , 2-Thi~barhituric acid (VII) was converted to 6-hydr_oxy-3-methyl-2-(methylthio)-4(3II)pyrimidinedfone {VIII) via methylation with dimethyl sulfate.

Chlorination of VIII with

phosphorus oxychloride in the presence of N,N-dimethylaniline gaye the corresponding
chloro derivative (IX) in 57% yield.

Compound IX was hydrolyzed in dilute acid to

yield 31-4 7% of 6-chloro-2-hydroxy-3-methyl-4(31I)pyrimidinone (X) which was nitrated
readily Lelow 25° to give 6-chloro-2-hydroxy-3-methyl-5-nitro-4(3H)pyrimidinone
in 45% yield.

(XI)

Catalytic reduction· of XI in methanol containing 3: small amount of

aqueous ammonia, and then addition of formic-acid anhydride to the concentrated
reaction

mixture

(XII) in 43% yield.

gave 6-chloro-5-formamido-2-hydroxy-3-methyl-4(3H)pyrimidinone
Compound XII was then refluxed with one equivalent of me~hyl-

hydrazine in ethanol. The resulting precipitate was dissolved in a saturated amruoniuin
sulfate solution, which was extracted with chloroform.

Evaporation of the chloroform·

extract and recrystallization of the crude product from 1-propanol gave a 28% yield of
toxoflavin (VI) m.p. 172-173° dee.
The synthetic toxoflavin exhibited identical ir and uv absorption
1.7) 257.7 nm (€, 16,400);

p..max

(pH

394 nm (E, 2,500)] with that of the natural product.·

7
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Figure 3. Synthesis of Toxoflavi,n
,,

NH-CH=O
'

. 8

It is of interest to note that one of the first recorded observations of van Veen and
:\Iertens (1) in 1933 was the close structural resemblance of toxoflavins to Warburg's
']

"yellow-pigment"

and the "flavins".

,

~

f

The actual structural relationship of toxoflavin

to riboflavin (XIII) is truly striking, since both compounds possess similar oxidationreduction systems.

CH20H
I .
HOCH
I

HOCH
I

HOCH
I
CH2
I

c(X. I'!'._~
t~~N,--._✓,,o/•
r

H3

H C ~
3

'-N~-

.

I

-- ~NH
I

0

Xill
· Figure 4. Structure of Riboflavin
Structure and Properties of Fervenulin
Fervenulin, a new crystalline antibiotic isolated by Eble and co-workers (8)
from culture filtrates of an actinornycete (from a California soil), Streptomyc_cs fervens,
ha;;; demonstrated

broad-spectrum antibacterial, antifungal, arltiparasitic and antitumor

cell activity in vitro. This a/itibiotic is of interest since the proposed empirical formula
C7 H7 N5 0 2 (8) is idmtical with that of toxoflavin (VI). The_ ultraviolet absorption
spectrum of ferveuulin is not identical, but strikingly similar. to that of toxoflavin.
F'ervenulin, like toxoflavin, is readily reduced electrolytically.
frrvenulin is isomt!ric with toxofla\.in.
structure

of fervenuiin

This suggested that

Daves, Robins aml Cheng (9) established the

(XV) as 6,8-dimethyl-5,7-dioxo-5,6,7,8-tetrahydropyrimido-

[ 5,4-e ]-as-tria'./,ine. They prepared it, using the method of Pfleiderer and SehiindehUtte
(10) by thf' reductive cyclization of l,3-dimethyl-2,4-dioxo-5-nitroso-6-formylhydrazino-

9

1,2,3,4-tetrahydropyrimidine
acid and formamide.

(XIV) with sodium hy<lrosulfite in the presence of formic

The syrithetic fcrvenhlin v;·asfound to be identical to the natural

product.

~H3

oy:;N

N=O

CH,,...N
3

I NH-NH-cH_=_o__

0

Figure 5. Synthesis of Fcrvenulin

The infrared and ultraviolet absorption
(E, 1,600) and 340 nm (E, 4,200)]

p" max

(ethanol) 238 nm (€, 18,500), 275 nm

of the synthetic co~1p<?undand those of the natural

product proved to be identical.
The structure of f ervcnulin and that of toxoflavin have providetl' a new class
of antibiotics with the pyrimido [4,5-c] -as-triazine ring system.

Biological Studies on Toxoflavin and Fervenulin

In 1954 an antibiotic, called xanthothricin, was isolated by Machlowitz et al:
(11) from a culture of a member of the genus Streptomyces.

Owing to tfic high toxicity

of this antibiotic '(intravenous toxicity (LD 5 0 ) of 1.7 rrig./kg. and oral toxicity (LD 5 0 )
of 8.4 mg./kg. on mice) no work on the chemical structure was done.

.

I

,

Later Daves,
.

~•

.Robins and Cheng (7) confirmed the '.identity of t~xoflavin
with xantliothricin
.

by a

comparison of the synthetic toxofl~vin with an authentic sainple 'of the antibiotic.
In l 961, Latuasan and Berends (12) studied the toxicity of toxofl,avin. They found that

although toxoflavin inhibited the growth of several micro~rgatiismti at low concentrations,
·'

it did not effect the growth of yeast (Saccharomyces cerevisiae ). The antibiotic activity

10
of toxoflavin was determined bv the dilution method.

Growth inhibition of yeast
i

cells by toxoflavin to concentrations of 100 µg./ml. could not he obs~rved in ~tati_onary
or in shaking cultures.

Table I
Growth Inhibition by Toxoflavin
Microorganism

Concentration of Complete
Inhibition of Growth (µg./ml.)

0.5

E. coli
Shigella
Alicrococcus pyogenes

1.2

L2

2.5
25.0 -

Bacillus subtilis

Proteus vulgan·s

The endogenous respiration of yeast cells ·suspended in a phosphate buffer
was considerably

increased by toxofla~in (80-100%).

cons um ptio 11 · by toxofla\in

of oxygen

was almost the same for commercial pressed yeast, drie,1'

yeast or yeast cultivated in a ·whiffen medium.
the ananobic

The stimulation

Toxoflavin did not show any effect on

fermentation of glucose by intact cells or homogenates of pressed yeast.

It did not inhibit but rather slightly promoted the oxidative phosphorylation in a Nossal
homogenate of yeast at pH 6.3 (internal P-tl of yeast .cells).

..

I

The by-passing of the cytochrome system by toxoflavin was deduced

from

the study of the effect of toxofla,in on inhibitions caused by inhibitors of the ~~spiration
of yeast.

The antibiotic, antimycin ~:, i_r;t~rcep_tsthe trinsfer of ;l~ctrons,betwe?
;·

the
f

cyto,;hromes b and c. Traces of antimycin ,blocked the endogenous respirati9n of yeast
....

almost completely,

-

.....

..::

whereas the carbon dioxide production
·,

effects were annihilated by ·the addition of toxoflavin (lQrespiration completely.

4

l!'.

-,These

M) which restored the

The endogenous oxygen consumption of a yeast homogenate

was found to be inhibited about .50% by 10aclenine-dinuclcotide containing enzymes).
effect completely.

was stimulated.

)

,

3

_ivlchlorpromazine (inhibitor of flavin-

Toxoflavin (10- 4 2H) could counteract this

11

The by-passing of the cytochrome system by toxoflavin was confirmed hy the
following experiment.

Saccharomyccs

cerevisiae Pfaff 300 is a cytochrome deficient
l

l

yeast that almost exclusively sho,vs fermentation

and no respiration.

Toxoflavin,

however, brought about an oxygen uptake in the absence as well as in the presence of
glucose. Considering the function of toxoflavin as an electron-transfer agent, Stern (13)
measured the redox potentials of toxoflavin. ·He found H~at toxoflavin had the role
of an oxidant in an oxiclation-reduction system which was fully reversible and electroactive between pH 4 and pH 8. Toxoflavin was found to absorb one mole of hydrogen
'·

in the presence of a 10% palladium catalyst in acetic acid at room temperature.

After

removal of the catalyst, this solution was shaken w:ith air a~d re~oxidatio~ of toxoflavin
occurred very rapidly.

The same reduction took place anaerobically by a yeast homo-

genate to which NADH had been added.

It may be deduced that toxoflavin acted as

an electron-carrier between NADH and oxygen.
NADH + toxoflavin ➔ NAD+ + toxoflavin - H2
toxoflavin - H2 · +

02

➔

toxoflavin + H2 0 2

The presence of hydrogen peroxide· was demonstrated
containing toxoflavin hy the method of Aebi (14).

in . the homogenates

A negative reaction was obtained

upon omitting toxoflavin or yeast extract from the reaction mixture.

Hydrogen

peroxide is a very strong poison to catalase-deficient cells. The high catalase content of
yeast may explain the fact that the growth of yeast is not inhibited by toxoflavin.
The formation of hydrogen peroxide being responsible for the toxicity of
toxoflavin was demonstrated

by the presence of hydrogen peroxide in cultures of

E. coli, a microorganism highly sensitive to toxoflavin, to which to?'oflavin has been

added.

According to the figures given in Table II toxoflavin strongly inhihits the

oxygen consumption of E. coli (12).

Table II·
Substrate
0.05 M glucose
0.05 M pyrnvate
0.05 M succinate

QO2
+10 µg. toxoflaviri

Blank

42

80

152

29
88

245

According to Stern (13), toxoflavin stimulates the oxygen uptake of erythro·cytes

very strongly,

while the oxyhaemoglobin

is converted

to methaemoglobin.

The lack of antibiotic activity of toxoflavin in anaerobic conditions also supports the
hypothesis

that the poisonous effect of toxoflavin

is always due to the hydrogen

peroxide formed.
Fcrvenulin, which is isomeric with toxoflavin, was investigated by De Boer,
Dletz, E,vans and Michaels (15) who reported the following biological activities
Ant~'l:o!ozoal

tnvitro.

Activity

Using a broth dilution technique,

fervenulin inhibited

and Trichomonas vaginalis at 20 µg./ml. and Entamoeba

Trichomonas foetu~

histolytica

Tissue Culture

at 80 µg./ml.

,.·

It was found that the cytotoxicity

of fe~venulin to KB human epidermoid

carcinoma ceJls in viiro caused 50% in!iibition of KB protein synthesis (ID 5 0 ) when

15 ,ug./ml. were used.

Even though this· is marginal, the Tompound was <;o!lsidered
'l

'

i

~

worthy of in vivo antitumor evaltw.tion on the basis· of its in vitro cytot?xicity.
Antibacterial Activity
A broth dilution spectrum
against Mycobacterium

(Table III) revealed that fervenulin was active

bovis and gram-negative and gram-positive

antibiotic was also active against bacterial plant pathogens.

bacteria.

This
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Table III
· Antibacterial Spectrum of Fervenulin
Test Organism

Minimal inhihitory concentration; ,
µg./ml.
- 3.1

Pasteurella multocirla
Salmonella pullorum
Aerobacter aerogenes
Bacillus wbtilis
Salmonella typh osa
Salmonella paratyphi B
Escherichia coli
f{lebsiella pneumoniae
Mycobacterium boliis (BCG)
Diplococcus pneumoniae
Streptococcus hemolyticus
Staphylococcus alb us
J>roteus vulgaris
Staphylococcus aureus
Streptococcus viridans
Agrobacterium tumefaciens
Corynebacterium fascians
Corynebacterium michigan ensis
Erwinia amylovora
Xanthomonas campestris
Xanthomonas pelargonii
Xanthomonas vesicatoria
Xanthomonas malvacearum

25

25
50
50
50
50

25

~

50
100
10
100
100
1
100
200
100
100
200
200
200
200
200

Antifungal Activity
~

,.

r-,

In an agar dilution test, Hist6plasma capsulatum was inhibited •at 10 µg./rnl.
0

Several other fungi were inhibited at 100 µg./ml.
in Table IV.

-t,

~

.,,

The antifungal spectrum is given
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Table IV
Antifuilgal

Specfrti1n
·of ]?ervenulin-7,

Test Organism

Minimal inhibitory concentration,
µg./ml.

Geotrichum sp.
llormodendrum
compactum
Cryptococcus neoformans
/Iistoplasma capsulat11m
Sporotrichum schenckii
1/onosporium apiospermum
Microsporum audouini
Candida albicans Abbot
Candida albicans McKinney
Candida albicans Upjohn
illicrosporum canis
Trichophyton interdigitale

<.

1000
100

Nocardia astcroides
Blastomyces dermatitidis
Coccidioides immitis ·

1000 (100 partial
. inhibition)

-I

'

iooo

···1000,

loo

10
1000
1000

100

> 1000
> 1000
> 1000
100
100

*Fungal spectrum agar in g./1. of distilled wat~r: dextrose, 10; bacto
peptone, 5; yeast extract, 1; bacto agar, 20. Adjust pH to 6.8.

The biological activities in vivo were the following.
Anlitrichomonal Activity
Infections with T. vaginalis and T. foetus were established in mice by subcutaneous injections. Infections of T. foetus in hamsters were established

intravaginally.

Therapy was attempted by administering fervenulin orally, intraperitoneally,
cutaneously to mice at the site of infection; intraperitoneally
hamsters.

The results are compiled in Table V and VI.

and sub-

and intravaginally to
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Table V
Antitrichornonal

Activity of Fcrvenulin in .Mice

No. ·of daily
treatments

CDso,
mg./Kg./ day

3.4
4.4

Species

Drug route

T. vaginalis

Subcutaneous
Oral
Intra peritoneal
Intraperitoneal
Intraperitoneal
Intraperitoneal

6
6

;:,

4.1

Subcutaneous
Oral
Intraperitoneal

6
6
6

2.5
3.5
3.0

T. foetus

1

3
,.

6

LDso,
mg./Kg.

,.

65

7.5
5.4
3.9

Table VI
Antitrichomonal

Acfoity of Fervenulin in Hamsters Treated Daily for 14 Days

Drug route

In traperitoneal
Intraperitoneal
Subcutaneous
Subcutaneous and intraperitoneal*

Drug dose,
mg./Kg./ day

·Per cent ·
cured

LDso,
mg./Kg.

4
2
4
4 and 4

75

11.2

0
0

84

*Combined therapy by both routes.

Antitumor Activity

i

,.-"'

The antibiotic was inactive against sarcoma 180, Ehrlich carcinoma ascites, both
'

Walker and Guerin adenocarcinoma, Murphy-Sturm lymphosarcoma and Jensen sarcoma,
when tested at l_Oand 20 mg./kg./day.
Antimicrobial Activity
Fervenulin

was inactiYe in nuce against Streptococcus

hemolyticus

and

K. pneumoniae at 12.5 rng./kg. Histoplusma capsulatum and Cryptococcus neoformans

up to IO minimal bactericidal doses, and influenza A (PR-8) virus at. 6.25 mg./kg. As
with toxoflavin, the toxicity of fervenulin to living systems has prevented investigations
of this substance as successful· antibiotic and antitumor agents.

· Review of the Pyrimido [4,5-c] pyridazine Ring System
The pyrimido [4,5-c] pyridazine ring system was first synthesized by Jones (16f
He allowed pyridazinediamide

(XVI) to react with alkaline hypobromite

(Hoff~an

reaction) and isolated a polynuclear compound to which he tentatively assigned the
pyrirnido[ 4,5-c] pyridazine structure (XVII).

Nakagome, ·Castle and 1\1urakami (17)

in 1968, reexamined the reaction and found that Jones had assigned the co~rect structure
to the major product, and that one other ring system was also formed as well as a third
product.

1

One of these is the pyrimi<lo[S,4-c]pyridazine ring system' (XVIIl) hut the

structure of the third prodtict has not yet been elucidated.
\

R

xv111
Figure 6. ·Hoffman Rearrangement of Pyridazinediami<le

Druey (18) in 1958 indicated in a review the possibility of syntl1esizing the
pyrimido[ 4,5-c] pyriclazine ring system (XX) from 3-amino-5,6-dim,ethyl-4-carboxamidopyridazine (XIX), but no experimental details were given.
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Figure 7. Synthesis of the Pyrimido[ 4,5-c] pyridazine Ring.,.System .

1n the same year, Pfleiderer and Ferch (19) showed that when l,3-dimethyl-

4-hydrazinouracil

(XXI) was treated with 1,2-dicarbonyl compounds, such as 1,2-

diketones or a-keto

esters, derivatives of pyrimido[ 4,5-c] pyridazine

(XXII) could

be obtained in good yields.

+

XXII
Figure 8.

Synthesis of Derivatives of Pyrimido [ 4,5-c] pyridazine

When R = H, a bis-hydrazone, was isolated as well as the cyclic product:
Yanai, Kinoshita, Watanabe and Iwasaki (20) synthesized several new com-.
pounds containing the pyrimido [-1,5-c]pyridazine (XXIV) ring system utilizing 3-amino4-carbamoylpyridazines (XXIII) as the starting material.

· 18

¢
R

.
H2N-~
0

N

II

N
. NH2

R = H, Cl

xxIV

XXIll

Figure 9. Synthesis of the Pyrimido [4,5-c] pyridazine Ring System
Recently, Wagner (21) synthesized some analogs of toxoflavin: 4-deazatoxoflavin (XXV)
and l-benzyl-4-deazatoxofla\in
uracil.

(XXVI) from the corresponding 6-hydrazino-3-methyl-

The main intermediate in these syntheses was 6-chloro-3-methyluracil prepared

from 2-thiobarbituric acid by the method of Daves, Robins and Cheng (7).

H-C-C-H
II

ll

0 0

+ bis-hydrazone

H-C-C-H
II

11

0 0

xxvl
Figure 10. Synthesis of 4-Deaza-toxoflavin and Anologs.

19
Review of the Pyrido[2,3-d] pyrimidine Ring System
In 1923, Klisiecki and Sucharda (22) claimed to have prepared 4-hydroxypyriclo [ 2,3-d] pyrimidine (XXVII) from 2-aminonicotinic acid and formamide.

O

·~N

COOH

N

~-~.~'~,)
N
N ,

NH2

xxvII

Figure 11. Synthesis of 4-Hydroxypyrido [ 2,3-d] pyrimidine
I

'

McLean and Spring (23) prepared 2,4-dihydroxypyrido[2,3-d]
(XX VHI) from quinolinic acid amide and sodium hypobromite.

pyrimidine

They obtained only

the p_yrido[2,3-d]pyrimidine isomer.

J

I.

~N

I

0
II
C-NH 2

C-NH
11

0

OH
NaOBr

2

~N

.

0

-'~NH

lN~N.;~ .lN~NJ-0
H

XXV111
Figure 12. Hoffman Rearrangement of Quinolinic Acid Amide

Upon chlorination of XXVIII with phosphorus oxychloride, they obtained 2,4-dichloroP)Tido [ 2,3-d] pyrimidine.
Robins and Hitchings (24), in 1954, attempted lo prepare 4-hydroxyp)Tido[ 2,3-d] pyrimidine (XXVII) from 2-aminonicolinic acid and form amide a~cording to the

,20

directions of Klisiecki and Sucharda (22) but they only recovered the.starting

material. ..

By increasing the amount of formamide and altering the reaction time, temperature and
isolation procedure, they obtained a good yield (70%) but a product with considerably
lower melting point (258°, instead of

> 385° observed by Klisi~cki' and Sucharda).

Robins and Hitchings (24) also repeated the synthesis of 2,4,dihydroxypyrido-.

[ 2,3-d] pyrimidine

(XXVIII) follo~ving the directions

of McLean 'a~d Sp~ii~g (23).

Because of the low yield of the intermediate, they searched for another route, starting
with 2-aminonicotinic acid and urea.

+ NH2-C-NH
II
0

~NH

2

~NA"N~O
H

xxv111.
Figure 13. Synthesis of 2,4-Dihydroxypyrido[2,3-d]

The use of substituted

2-aminonicotinic

pyrimidine

acid has enabled a series of pyrido[2,3-d]-

pyrimidines, which have 5,6 and 7 alkyl and aryl substituents to be obtained. ··Dornov
and Hahmann (25) have been able to synthesize compound
dimethylnicotinic

acid and nicotamide.

with cthvl chloroformate
,I

and urea.

XIX from 2-amino-4,6-

The latter has the advantage of condensing

under less drastic conditions

.

that 2-aminonicotinic

acid
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'•',

H

CH3Q(N
. ' I N~oI

potassium

CI.Janate

,

~

.«

NH

,

.

'

. . CH
·-

;

0

3

xx1x

.

,•r

'

.·

..

,:!,,,
l

,i

,l

.,.

Figure 14. Synthesis of 5,7-Dimethyl-l,2,3,4-tetrahydropyrido[2;3-d]-2,4pyrimidinedione

·

Another approach in the synthesis of pyrido[ 2,3-d] pyrimidines has been to
start from 4-aminopyrimidines and to condense them with /J-dicarbonyl compounds S)JCh ·
as diketones, dialdehydes and keto-aldehydes.

It was proposed by Ridi, Checchi and
.

Papini (26) and confirmed by Robins and Hitchings (27) that 2,4-dihydroxy-6-aminopyrimidine

condenses with

1,3-dicarbonyl

compounds

to produce

.

pyrido (2,3-d]-

pyrimidine derivatives (XXX).
t_

...,_

,....;.,

.:/_.

.k ··-

.... ..

I'

_,"'
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4

or

-

Figure 15.

P2 o5
>

100°

Synthesis of 2,4-Dihydroxy-5-methyl-7-phenylpyrido[2,3-d] pyrimidine .

Two series of carbocondensed ,.pyridopyrimidines

.•

'
were ·developed
by Robins and

Hitchings (24) primarily to provide derivatives with a d~versity of functional groups
in the pyrimidine moiety.

The investig~tions of Rydon and co-workers (28) follow:ed

similar lines.
Robins and Hitchings (27) have synthesized a considerable immber of ·new
pyrido [ 2,3-d] pyrimidines (XXXIIl) by condensing a 4-aminopyrimidine with ~-dik.etone
or 11-ketoaldehyde.

xxx1

xxx11

XXXIII

Figure 16. Synthesis of Pyrido[2,3-d] pyrimidine De~ivatives
Variations in the pyrimidine ring and in the dicarbonyl reagent were investigated. When
acetylacetone (XXXI, R 1 , R 3 = CH3 , R 2 = J-1)was heated with pyrimidines (XXXII}
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bearing hydroxyl, amino or mercapto groups in both the 2~ and 4-positions, cyclization
occurred.

But no product was obtained ,vith either 2,4-diamino-6-methyl or 6-amino-

. 4-hydroxy-2-methylpyrimidine.

Alkylated derivatives of acetylacetone

dione) do not condense as well as acetylacetone itself.

(pentane-2,4-

Alkyl substituted

3-keto-

aldehydes, on the other hand, appeared to give bette.r yields than the unsubstituted
derivatives.

This was probably ·due to the self-condensation of the latter.

In acid

conditions, formylacetone is reported to give triacetylbenzene (27) and formylaceto~
phenone gives tribenzoylbenzene

(30).

This type of self-condensation to aromatic

derivatives is blocked by the ,alkyl siibstitutiont

In the case of unsymmetrical dicarboriyls, the condensation always occurred
in such a way that the more reactive carbonyl will condense at th~ 5-position of the
C

pyrimidine ring (activated position).
Bernetti,

.The product. was foundof

Mancini and Price (31) investigated the condensation

malonaldehyde ·with 2,4-diamino-6-hydroxypyrimidirie.

2-amino~4-hydroxy-6-nitropyrido[2,3-d] pyrimidine (XXXIV, Y = N0 2 ).
synthesized a number of related compounds.

XCH(CHO)
2

xxx1v
X = N o2 , H, COOEt

..

-N==N-c 6 H4 NMe 2

Figure 17. Svnthesis of 6-Substitutcd Derivatives of 2-Amino-.
4-hydroxy-pyrido[2,3-d] pyrimidine

nitroto he_

Tliey also
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The nitro group in the dialdehyde was found to fai;ilitate the condensation so that it
occurs under much milder conditions than those reported earlier for other

J ,3-dicarbonyl

compounds (26,27).
Compound XXXIV (Y = H) was synthesized from malonaldehyde tetramethyl
acetal.

The product formed was the di~nil which was converted to XXXIY (Y = H) by

hot concentrated sulfuric acid.
Recently, Wagner (21) attempted

to synthesize 's-benzyl-3,5,7-trimethyl-

2,3,4,8-tetrahydropyrido [ 2,3-d] 2,4-pyrimidinedione (XXXV) following the method of

.',

xxxv
''

Figure 18. Structure of 8-Benzyl-3,5,7-trimethyl-2,3,4,8-tetrahydropyrido[ 2,3-d] -2,4-pyrimidinedione
Ridi, Checchi and Papini (26) under varying conditions but was not successful. Attempts ·
to synthesize l-benzyl-2,3-dideazatoxoflavin via Michael addition with acrolein were also
unsuccessful.

·~

III.

EXPERIMENTAL

Melting points were taken in capillary tubes in an electrically heated oil bath
and in a melting block for melting points above 300° and ~re uncorrected.

The nmr

spectra were obtained in trifluoroacetic acid and deuteratcd dimethyl sulfoxide on a
Varian 60A Spectrometer

and chemical shifts are repode~ in parts per million (6)

downfield from an internal T.MS reference. Infrared spectra ,~ere obtaif!-ed on potassium

bromide pellets on a Hilger and Watts lnfragraph Hl200 Spectrometer.
Ultraviolet
"'
·spectra were recorded in ethanol solutions·onca·Cary·Model 14 Recording Spectrometer.
!

..

6-Chloro-3-methyluracil (X).

t

This compound was· prepared from 2-thiobarbituric acid according to the
method of Daves, Robins and Cheng (9).

6-(<~-Methylhydrazino)-3-methyluracil_(XXXVI).
This compound was prepared from 6-chloro-3-methyluracil acc~rding to the
method of Daves, Robins and Cheng (9).

1,3,4,6-Tetramethyl-l ,5,6, 7-tetrahydropyrimido [4,5-c ]-5, 7-pyridazinedione (XXXVII).
To a boiling solution (0.5 g., 0.003 mole) of 6-(o:-methylhyd.razino)-3-methyluracil (XXXVI) in 15 ml. of water was added dropwise 0.6 g. (0.006 mole) of 2,3butanedione.

Upon cooling, some yellow needles precipitated out of ·solution.

The

product was filtered and dried, yield 0.56 g. (84%), m.p. 235-237° dee. The analytical
sample was purified by recrystallization from absolute ethanol; uv A max (nm) (95%
25

·•.

26

ethanol):

325 (E, 3,380), 277 (E, 2,470);

(singlet, 3H), 3.58 (singlet, 311),

0

nmr

1.?7(singlet,

o (in

TFA):

3H); ir v (cm-

2.84 _(singlet, 3H), 3.16
1

~950 (C-H), 1700

):

(C=O), 1650 (C=O), 1380 (C-H).
Anal. Calcd. for

54.39;

H, 5.51;

cl

O

HI 2 N4 02:

C, 54.54;

H, 5.49; N, 25.44. -Found:

C,

N, 25.56.

l ,6- Dimethyl-3,4-diphenyl-1,5,6,7-tetrahydropyrimido

[4,5-c] -5,7-pyrida,-,inedione

(XXXVIII):
6-(ll'.-Methylhydrazino)-3-methyluracil (XXXVI) (0.36 g., 0.002 mole) arid 0.42
g. (0.002 mole) of benzil in 25 ml. of 2-methoxyethanol was refl~xed overnight. The
solution ·was allowed to cool and the yellow product which formed was filtered and
dried, yield 0.17 g. (25%), m.p. 308-310°.
rc1:;rystallizatio11from 2-methoxyethanol;
26 l (E, 16,290), 217 (E, 15,590); nmr

The analytical sample was purified by

uv A max (nm) (95% ethanol): 348 (E, 5,030),

o (in TFA):

3.55 (singlet, 3H), 4.78 (singlet, 3H),

7.02-7.64 (multiplet, lOH); ir v (cm- 1 ): 1700 (C=O), 1660 (C=O), 740 and 700 (monobenzene ring).

suhstiluted

Anal . . Calcd. for C2 0 H16 N4 0 2 • 1/2 H2 0:

Found:

C, 67.69;

H, 5.05;

C, 67.98;

H, 4.85;

N, 15.85.

N, 15.63.

6-Hyd razino-3-methyluracil (XX XIX).
6-Chloro-3-methyluracil (X) (1 g., 0.006 mole) in 100 ml. absolute ethanol,
0.35 g. (0.01 mole) of anhydrous hydrazine and 1 g. of triethylamine was refluxed on
a steam bath for 3 hours. The reaction mixture was allowed to stand overnight in the
I

refrigerator.

The white product formed was filtered, washed with absolute ethanol and

ether, then recrystallized from ethanol, P.-eld 0.55 g. (59$'.6),m.p. 223°;
D~ISO-d6 ):

3.04 (singlet, 3H), 5.21 (singlet, HI), 6.1-(broad,

3250 (N-H), 3080 (=C-H), 1640 (C:::O), 1630 (C=O).

N-H);

nmr 6 (in

1r v (cm- 1 ):
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3,4,6-Trimethyl-5,6, 7,8-tetrahydropyrimido [4,5-c ]-5, 7-pyridazinedione (XL).
6-Hydrazino-3-methyluracil (XXXIX) (0.55 g., 0.0035 mole) was dissolved in
60 ml. hot ethanol.

2,3-ButaiieHior'te (1

g.,0.0ll6

mole) was added dropwise. The

solution was brought to the boiling point. · A white precipitate appeared immediately
and the solution was allowed to cool. · The precipitate was· filtered, washed with cold
ethanol and dried. Additional product was obtained upon concentration of the filtrate,
yield 0. 70 g. (97%), m.p. 261-263°. The a~alytical sample wa~ puri~ie_d,byrecryst~llization from ethanol; uv A max (nm) (95% ethanol): 323 (€, 13,540), 268 (€, 10,980), 238
(€, 13,950); nmr 6 (in TFA):

6.37 (broad, NH); ir

2.27 (singlet, 3H), 2.79 (singlet, 3H), 3.54 (singlet, 3H),

11 (cm- 1 ):

3200"(N-H), 1710 (C=O); 1680 (C=O),.13.65 (C-H in

Anal. Calcd. for C9 H 10 N 4 0 2 • l H2 0:

C, 48.35;

H, 5.30;

•

C, 48:21; H, 5:3~; N, 24.99. Found:

N, 24.88.

6-l\Iethyl-3,4-diphenyl-5,6, 7,8-tetrahydropyrimido [4,5-c ]-5, 7-pyridazinedione (XLI).
6-Hydrazino-3-methyluracil (XXXIX) (0.55 g., 0.0035 mole) and 0. 74 g.
(0.0035 mole) of benzil in 60 ml. of 2-methoxyethanol was refluxed overnight. ,The
solution was concentrated and upon cooling, some yellow crystals separated. They were·
filtered and dried. Because of the difficulty encountered in attempting recrystallization,
the yellow precipitate was washed with ethanol, acetic acid,, water and dimethyl-.
formamide respectively, yield 0.26 g. (23%), m.p. 337-338°;

nmr 6 (in TFA):

(singlet, 3H), 4.1 (broad, N-H), 7.3-8.1 (complex multiplet, lOH); ir

11 (cm-

(N-H), 3100 (=C-H), 1680 (C=O), 740 and 680 (monosubsituted benzene ring).
results from analysis showed that the sample was not pure enough.

1

):

3.63
3300
The

-~ 28

Glyoxal-bis-6-hydrazone-3-methyluracil

(XLII).
'

.,1"

'

.

6-Hydrazino-3-methyluracil (XXXIX) (0.5 g., 0.0032 mole) was dissolved in
15 ml. of boiling water to which 2 g. of 40% aqueous glyoxal (0.012 mole) was added
dropwise. A brown precipitate formed immediately and was filtered and dried. Because
of the difficulty encountered in attempting recrystallization, the precipitate was washed
with ethanol, dimethylformamide and water, yield 0.2 g. (19%) m.p. > 300°; nmr' 5
(in TFA):

3.58 (broad, CH3 ), 5.8 (singlet), 6.7 (singlet), 7.61 (singlet); ir v (cm- 1 ):

3350 and 3200 (N-H), 1700 (C=O).
Anal. Calcd. for C12 H1 4 N8 04 ·4H 2 0: C, 35.4;. H, 5.46; N. 27.58.

Found:

C, ;{5.03: H, 5.41; N, 27.5.

Al tern ptcd Preparation of 6-~Iethyl~l ,5,6°,7-tetrahydropyrimido [4,5-c l -5~7-pyridazine<lion,; ( XLIII).

The filtrate from the above experim_ent was concentrated down but no crystals
scp:1ratc1l. The solution was evaporated to dryness leaving a viscous residue. ·Attempts

to cryt;tallize it from absolute ethanol, acetone and benzene failed ..•

3-J\!ethyl-6-(/3-phenylhydrazino )uracil (XLIV).
To 1.5 g. (0.009 mole) of 6-chloro-3-methyluracil (X) in 20 ml. of 85% ethanol
was added an excess of phenylhydrazine (2 g., 0.018 mole). The mixture was refluxed
for 3.5 hours.

The solution was then evaporated to dryness under reduced pressure,

leaving an orange residue which was recrystallized from 50% ethanol. The crystals were
filtered and dried, yield 0.83 g. (40%), m.p. 218-220°;

nmr 8 (in DMSO-d6): 3.06

(singlet, 3H), 3.37 (broad, N-H), 4.74 (singlet, lH), 6.58-7.4 (complex multiplet, C6 H5 ),
7.83 (singlet, lH), 8.21 (singlet, HI); ir v (cm- 1 ): 3250(N-H), 1720 (C=O), 1680 (C=O),
740 and 680 (monosubstituted

benzene ring).
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Cleavage of 3-Methyl-6-(.(3-phenylhydrazino)uracil (XLIV) withTin/Hydrochloric

Acid.

To 0.36 g. (0.0016 mole) of 3-methyl-6-(.(3-phenylhydrazino)uracil (XLIV) was
added 0. 75 g. of tin and 5 ml. of 10% hydrochloric acid. The mixture was heated on a
steam-bath for 15 minutes.

The

'i10tsolution

was decanted into 5 ~I. of water ~nd then

was made basic with 40% sodium hydroxide
extracted

several times with chloroform.

solutio_n., ;he

aqueotJS solution was

•

, The chloroform ' extract

was dried over

anhydrous sodium sulfate and evaporated to dryness. The product obtained was 6-amino3-rnethyluracil (XL V).

Hydrogenation

'.,-

over Raney

Approximately

"'l

i

.

nickel of 3-Methyl-6-(.(3-phenylhydrazino )uracil

0.6 g. of Raney nickel was added-to

a solution

(XLIV).

(!f 0.55 g.

(0.0()24 mole) of 3-methyl-6-(.(3-phenylhydrazino)uracil (XLIV) in 100 ml. of absolute
ethanol and hydrogenated overnight (approximately 70 ml. of hydrogen was absorbed).
The Raney nickel was filtered off and the filtrate was evaporated to dryness under
redi1c,~d pressure.
(in TFA):

The product obtained was 6-am~no-3-methyluracil (XL~);'

3.56 (singlet, 3H), 4 ..5 (singlet, lH), 7.54 (broad, N-H); ir v (cm-

1

nmr
):

o

3400

and 3300 (doublet, -NH2 ), 3200 (NH), 2900 (C-H aliphatic), 1690 (C=O), 1660 (C=O).

Attempted Cyclization of 3-Methyl-6-(.(3-phenylhydrazino)uracil (XLIV) with 2,3-Butanedione.
To 0.5 g. (0.0022 mole) of ~-methyl-6-({3-phenylhydrazino)uracil (XLIV) was
added 0.5 g. of 2,3-butanedione in 30 ml. of 2-methoxyethanol.
was refluxed for 40 minutes, after which it turned dark.

The reaction mixture

Crystals did not form upon

cooling. The solution was evaporated to dryness to give a dark brown residue which was
dissolved in hot ethanol.
filtered.

Upon cooling, some brown crystals ,precipitated out and were

Nrnr data showed that no cyclization occurred.
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6-i\Icthylamino-3-methyluracil

(XL VI).

The solution of 1 g. (0.006 inoie) of 6-chloro-3-methyluracil

(X) in ~5 ml. ~f

40% aqueous methylamine was heated in a pressure bottle at 105° for _3 hours. After
cooling overnight, crystals did riot form.

Upon concentration

of the solution, some

yellow crystals precipitated out. They were filtered, washed with cold water anddried,
yield 0.41 g. (44%), m.p. 295-297°;

Attempted

Synthesis

ir v (cm-

1

):

3380 (N-H), 1720 (C==O),1690 (C=O).

of 3,8-Dimethyl-2,3,4,8-tetrahydropyrido[2,3-d]-2,4-pyrimidine-

flione (XL VII).
6-lVIcthylamino-3-methyluracil (XLVI) (0.4 g., 0.0026 mole) was mixed with.
2.2 g. of phosphorus

pentoxide..

Enough malonaldehyde

bis-dimethyl

acetal was

added to moisten the dry materials (10 ml.). As soon as reflux started, a dark brown mass
formed which was extracted with boiling ethanol.

The hot ethanol solution was allowed

t•J cool. A brown product precipitated out, was filtered and dried. Spectral data showed
that cyclization did not occur.

8-Mctltyl-6-n-propylaminouracil

(XL VIII).

A solution of 1 g. (0.006 mole) of 6-chloro-3°methyluracil (X) in 4.5 g. (0.076
mole) of n-propylamine was heated in a pressure bottle at 78° for 3 hours. After ~ooling
overnight, a product did not separate.
recrystallized from 95% ethanol.

The solution was evaporated to dryness and

The yellow crystals were filtered, washed with cold

ethanol and dried, yield 0.25 g. (23%), m.p. 241-242.5°.
purified by recrystallization from ethanol;

The analytical sample was

mnr ~ (in DMSO-d 6 ): 0.9 (triplet, 3H), 1.45

(multiplet, 2H), 3.04 (singlet, 2H), 3.11 (singlet, 31-1),4.58 (singlet, lH), 5.87 (singlet,
OH), 6.08 (hroa<l, NH);

ir v (cm-

1

):

3310 (N-H), 3050 (==C-H),1720 (C==O), 1_640

(C=O), 1380 (C-H in CH3 ).
Anal. Calcd. for C8 H 13 N 3 0 2 • l/2H 2 0: C, 49.99; H, 7.34; N, 21.86. Found;
C, 49.99;

H, 7.30;

N, 22.04.
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Attempted Synthesis of 3-:\Iethy1-8-n-propy1-2,3,4,8-tetrahydropyrido[2,3-d]-2,4-pyrim-

(XLIX).

idinedione

To 0.22 g. (0.0012 mole) of 3-iuethyl-~-n-propyl~minouracil (XL.VIII) in 8 ml.
of water and 0.2 ml. of conce~trated acetic acid was added 0.4 g. (0.0024 mole) of
malonaldehyde bis-dimethyl acetal in 7 ml. water. The mixture was refluxed overnight.
The hot solution was filtered, cooled. and chilled in an ice-bath. ·SomJ orange crystals
precipitated out, were filtered and dried. The analytical data indicated cyclization did\

/"

not oc<~ur.
L

- 1.

•.

Attempted Synthesis of 3,5,7-Trimethyl~8:n-propyl:2,3,4,8-tetrahydropyrido[2,3-d)-2,4pyrimidinedione (L).
3-Methyl-6-n-propylaminouracil
wjtl;

(XL \'III)

(0.4 g., 0.0022 mole) was mixed

l.2 g. of phosphorus pentoxide and 8 g. of 2,4-pentanedione.

refluxed for 1.5 hours.
!wiling water.

The mixture was

A brown resinous mass was obtained which was washed with

The precipitate was then recrystallized from ethanol.

Infrared data

indicated mostly inorganic material.

6-11-Butylamino-3-methyluracil (LI).
Nlethod A.
One g. (0.006 mole) of 6-chloro-3-methyluracil (X) was added to 6.5 g. (0.089
mole) of n-butylamine and 5 ml. of water. The mixture was refluxed for an hour. The
solution was evaporated to dryness under reduced pressure. The residue was dissolved
iu an ethanol-cyclohexane mixture.

Upon concentration of the solution and cooling,

some yellow precipitated from the solution. They were filtered, washed with cold ethanol
and dried, yield 0.33 g. (28%)

32
Method B.
The solution of 1

g. (0.006

moie) of 6-chloro-3-methyluracil (X) in 7.95 g.

(0.1 mole) of n-buty~lamine was heated in a_pressure bo~tle at ll0° for. 3 hours. The.
solution was allowed to cooi overnight.

i

Crystals did not form.· The sol{1tion was

evaporated to dryness and the residue was recrystallized ,from ethanol, yield 0.57.g.
(48%), m.p. 232-233.5°.

The analytical sample was purified by recrY.stallizatic>nfrom
,r"

ethanol; nmr 8 (in D1\!ISO-d
0.9 (triplet, 3H), 1.44 (multiplet, 411), 3.~4 (singl~t, 2H),
6 ):
3.32 (singlet, 3H), 4.6 (singlet, lH), 6.02 (broad, NH), 10.1 (broad, OH); ir v (cm- 1 ):
3250 (N-H), 3100 (=C-H), 1720 (C=O), 1640 (C=O).

Found:

C, !52.47; H, 7.95;

N, 20.44.

Attempted Synthesis of 8-n-Butyl-3-methyl-2,3,4,8-tetrahydropyrido[2,3-d]-2,4-pyrimidinediont: ( LII).

To 0.4 g. (0.0022 mole) of 6-n-butylamino-3-methyluracil (LI) in 10 ml. of
waler and 0.1 ml. of concentrated acetic acid was added 0.76 g. (0.0046 mole) (?f
ma1onaldehyde bis-dimethyl acetal in 10 ml. of water. The mixture was refluxed for 3
hours and allow~d to cool.

Some orange crystals precipitated out of solution.

were "filtered and dried, yield 0.25 g. (46%), m.p. 188-190°.

The analytical sample

was purified by recrystallization from a mixture of ethanol and water;
DMSO-d6 ):

They

nmr l> (in

0.'93 (triplet, 3H), 1.44 (multiplet, 4H), 3.09 (singlet), 3;23 (singlet), 3.52

(broa<l singlet);

ir v (cm- 1 ):

2900 (C-H), 1680 (C=O),.. 1620 (C=O), 1380 (C-H).

Results of analysis shmved cyclization did not occ~1r.
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Attempted

Synthesis of 8-n-Butyl-3,5,7-trimethyl-2,3,4,8-tetrahydropyrido(2,3-d]-2,4-

pyrimidineclione (LIII).
6-n-Butylamino-3-methyluracil (LI) (0.5 g., 0.0025 mole) was mixed with 1. 7

g. of phosphorus pentoxide to wl1idiJo g. (0.01 inole) of 2,4-pentanedione was added.
The reaction mixture was refluxed for 1.5 hours. The brown resinous mass which was
obtained was washed with boiling water and recrystallized from ethanol. Infrared data
in<licatcrl the product was mostly inorganic material.

6-Anilino-3-methyluracil (LIV).
To 0.5 g. (0.0031 mole) of 6-chloro-3-methyluracil (X) was added 0.4 g.
(0.01):i:} mole) of aniline in ethanol (21). Hydrochloric acid was added to the ~olution to

bring the pH to about 4. ,The mixture was heated overnight at 100° in a pressure bottle ..
The reaction mixture was allowed to cool and a yellow precipitate formed. The precip'itate
was filtered and dried, yield' 0.28 g. (42%), m.p. 325-327°; ir v (cm- 1 ):

3250 (-NH),

1730 (C=O), 1660 (C=O), 740 and 700 (monosubstituted benzene ring).

3,5,7-Trimethyl-8-phenyl-2,3,4,8-tetrahydropyrido[2,3-d]-2,4-pyrimidinedione

(LV).

6-Anilino-3-methyluracil (LIV) (0.5 g., 0.0025 mole) was mixed ,vith 1.4 g.
of phosphorus pentoxide to which 10 g. (0.01 mole) of 2,4-pentanedione w:IBadded:
The reaction mixture was refluxed for 1.5 hours. A brown residue formed which was
recrystallized from ethanol, after being washed with boiling water.

The product was

filtered, washed with cold ethanol and dried, yield 0.3 g. (42%), m.p. 280° dee. The
analytical sample was purified by recrystallization from ethanol;
(95% ethanol):
nrnr

o (in TFA):

uv A max (nm)

367 (e, 8,530), 278 (e, 8,000), 25_5 (e, 11,760), 218 (e, 17,935);
2.44 (singlet, 3H), 3.13 (singlet, 3H), 3.5~ (singlet, 3H), 7.62 (singlet,

lH), 7.38-7.95 (complex multiplet, 5H); ir v (cm- 1 ):

3050 (=C-H), 1680 (C=O), 1640

(C=O), 1380 (C-H in CH3 ), 760 and 700 (monosubstitutecl benzene ring).
\.,

'
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Anal. Calccl. for C16 H 14 N 3 0 2 ·1/2 H2 0:

Found:

C, 66.65;

H, 5.34;

C, 66.42;

H,-5.23; 'N, 14.52.

N, 14.34.

6-Benzylamino-3-methyluracil '(LVI).

...,.

To 0.5 g. (0.0031 mole) of 6-chloro-3-methyh,iracil (X) in 25 ml. ethanol was
added 0.5 g. (0.004 7 mole) of benzylamine (21 ). Enough sodium hydroxide was added to·
the solution to bring the pH to about 10. A yellowish precipitate formed immediately ..
The reaction mixture was heated slightly and allowed to cool. The precipitate was filtered,
dried and recrystallized from· ethanol, using a Norit mat.

A colorless solution was

ohlainccl. Upan cooling, some white crystals precipitated"out of the solution. They were
filtered and dried, yield 0.36 g. (50%), m.p. 302-304°;

nmr 6 (in TFA):

3H), 4.66 (singlet, 2H), 7.38 (singlet, 5H); ir v (cm-

3250 (N-H), 3100 (=C-H), 2900

1

):

3.53 (singlet,

aliphatic), 1720 (C==O),1640 (C=O).

(CH

~-llydroxy-3,5,7-trimethyl-4(3H)pyrido[2,3-d]

pyriniidinone (LVII).

The procedure of Ridi, Checchi and Papini (26) was 1.1sedto attempt to prepare
B-benz yl-3,5, 7-trimethyl-2,3,4,8 -tetrahydropyrido [ 2,3-d] - 2,~- pyrimidinedione (XXXV),

imtcad

compound LVII was obtained.

6-Benzylamino-3-methy1uracil (0.5 g:, 0.0025

mole) was mixed with 1.4 g. of phosphorus pentoxide to which 10 g. (0.01 mole) of

2,4-pentanedione was added. · The reaction mixture was refluxed for 1.5 hours.

The

residue was washed with boiling water and recrystallized from ethanol, yield 0.2 g. (40%),
m.p. 242-244° dee.; uv A max (nm):_ 293 (€, 6,570), 257 (€, 2,150); 231 (€, 4,310);
nmr
HI);

o (in

TFA):

ir v (cm-

2.87 (singlet, 3H), 3.12 (singlet, 3H), 3.58 (singlet, 3H), 7.45 (singlet,
1

):

3200 (N-H), 1730 (C=O), 1670 (C=O), 1380 (C-H).

Anal. Calcd. for C10 H 1 1N

C, 58.55;

H, 5.63;

N, 20.08.

3

02

:

C, 58.53;

H, 5.40;

N, 20.48.

Found:

~-.
,,
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Attempted Preparation of 8-Benzyl-3,5, 7-trimethyl-2,3,4,8-tetrahydropyrido [2;3-d )-2,4=-•
pyrimidinedione (XXXV).
I

'

To 0.36 g. (0.0015 mole) of 6-benzylamino~3-methyluracil was added 7.5 g.
(0.075 mole) of acetylacetone in

'

'

.

30ml. of benzene

and a trace of phosphoric acid. The ,

mixture was allowed to reflux overnight under a Dean-Stark trap. The solution which
.

,.

formed turned dark red. The solution was evaporated and the residue was crystallized
from acetone.

Not enough crystals formed in order to_run spectral data (infrare~ and

nmr) and to get an analysis.

3-Ethyl-2-ethylthio-6-hydroxy-4(3H)pyrimidinone

(LVIII)./

To a stirred solution of 2-thiobarbituric acid (VII) (50 g., 0.347 mole) in 500
ml. of 2N sodium hydroxide, cooled in an ice-bath, was added 125 g. (0.81 mole) of ..
diethylsulfate over a period of 3 hours. The solution was stirred at room temperature
.,

overnight. Hydrochloric acid was added slowly to the solution a~d cooled in an ice-bath
until pH 1-2 was achieved. At this time, a viscous yellowish mass formed at the bottom
of the flask. The supernatant aqueous solution was decanted and the viscous product was
stirred iri anhydrous benzene upon which crystallization occurred. ·The white crystals
were filter.ed and allowed to dry. More product precipitated out of the ice-cold aqueous
solution, yield 15.8 g. (23%), m.p. 119-120°; nmr 6 (in DMSO-d6 ): 1.31 (triplet, 6H ),
3.11 (quadruplet, 2H), 4.24 (quadruplet, 2H), 5.38 (singlet, lH);

ir v (cm· 1 ):' 3250

(broad, OH), 2950 and 2850 (C-H aliphatic), 1650 (C=O), 1230 (C-O):
Anal. Calcd. for C8 H 1 2 N2 0 2 S· 1/2 H2 0:

Found:

C, 46.30;

H, 6.24;

N, 13.21.

C, 45.92;

H, 6.26;

N, 13.39.

)<.

:.
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Attempted Preparation of 6-Chloro-3-ethyl-2-ethylthio-4(3H)pyrimidinone

f::

(LIX).

Fifty ml. of phosphorus oxychloride and 7.5 ml. of N,N-dimethylaniline was
.

.,

~

.

added to 15.8 g. (0.079 mole) of 3-ethyl-2-ethylthio-6-hydroxy-4(3H)pyrimidone
I .

.,.

(LVIJI).

.

The reaction mixture was refluxed for' 3 hoilrs_ PH.osphorus oxychloride was distilled off
under reduced pressure and the residue was poured over crushed ice. The ice mixture
·,.

was allowed to stand overnight in the refrigerator. A viscous oily material separated, bu~ .
no crystals formed.

Attempts to crystallize it from benzene, ligroin, chloroform and

anhydrous ethanol failed.

,;
I.~

.,

IV.

'L1

_
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.

;
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DISCUSSION Of SYNTHETIC PROCEDURES

The mam intermediate for the synthesis of the 4-deaza and 2,4-dideazatoxoflavin analogs from 2-thiobarbiturie acid was 6-chloro-3-methyluracil (X);, An excess
of dimethylsulfate in dilute sodium hydroxide was use"d.to methylate -both the sulfur
r.

♦.

"

in the 2-position and the nitrogen in the 3-position of 2~Jhiobarbituric acid (VII). The
compound

obtained

Compound

VIII was chlorinated

N,N-dimelhylaniline

was 6-hydroxy-3-methyl-2-methylthio-4(3H)pyrimidone
with a mixture

(VIII).

of phosphorus oxychloride

to give 6-chloro-3-methyl-2-methylthio-4(3Jl)pyrimidoi:e

and
(IX).

The methylthio group in compound IX was hydrolyzed with hydrochloric acid to give ··
6-cliloro-:3-melhyluracil (X).
Compound X served as the intermediate for the synthesis of th,e following
:rnulogs of toxoflavin:

1,3,4,6-tetramethyl-l,5,6, 7-tetrahydropyrimido [4,5-c ]-5, 7-pyrida-

zincdfone (XXX VII); l ,6-dimethyl-3,4-diphenyl-l,5,6, 7-tetrahydropyrimido [4,5-c ]-5, 7-

pyridazinedione (XXXVIII);
[ 2,:{-dj-2,4-pyrimidinedione

'obtained

(L V). The following analogs of fervenulin have also been

from Compound X:

pyridazinedione

(XL);

pyrida'.linedione (XLI);

and 8-phenyl-3,5, 7~trimethyl-2,3,4,8-tetrahydropyrido-

3,4,6-trimethyl-5,6,7,8-tehahydropyrimido[

4;5-c ]-5,7-

6-methyl-3,4-diphenyl-5,6,7,8-tetrahydropyrimido[4,5-c]-5,7and 2-hydroxy-3,5, 7-triniethyl-4(3H)pyrido [ 2,3-d ]-2,4-pyrimi-

dinone (L VIII).

37

,,'

38

., '

.,

... '

xxxv11
H

H

oyNyN~,~

. 0rN1('7
CH

3

~CH

0

CH3

3

XC

CH3Nyyc5H5
0
.c6H5
XLI

Figure 19. Analogs of 4-Deaza and 2,4-Dideaz1;1toxoflavin

6-(o:-1'-Iethylhydrazino)-3-methyluracil (XXXVI).
The nucleophilic substitution of the chlorine atom in the 6-position of

6-

chloro-3-methyluracil (X) by methylhydrazine gave compound XXXVI. Because of the
strong electron withdra,dng effect of the nitrogen atom on the pyrimidine ring, positions
2,4 and 6 are ele~tron deficient and are susceptible to nucleophilic attack by nucleophiles,
in this case methylhydrazine.

Due to the electron-rel~asing effect of the methyl group in

methylhydrazine, the nitrogen attached to the methyl group is more nucleophilic than the
unsubstituted one.

39
-Because of the tautomerism which exists in 6-chloro-3-methyluracil (X), there
is an equilibrium between a keto and-an enol form. The hydroxy group in the 2 position
has a tendency to decrease the ease of substitution in the 6 position because it releases
electrons into the ring and causes

it to become more aromatic in character. In this

.

~

particular case, it did not seem to affect the reaction which occurred easily .
-

·,

~

...

1,3,4,6-Tetramethyl-l ,5,6, 7-tetrahydropyrimido [4;5-c] -5,7-pyridazinedione (XXXVII).
6-(a-Methylhydrazino)-3-methyluracil (XXXVI)was condensed with 2,3-butanedione to give compound XXXVII. This reaction proceeds via a nucleophilic attack of
the terminal nitrogen of compound XXXVI,.which has a !one pair of electrons, on the
carbonyl carbon of 2,3-butanedione which is electron deficient. The nitrogen attache'd,
to the double bond of compound XXXVI is less nucleophilic due to the· lone pair <?f
electrons involved in the resonance with the double bond and the carbonyl of the uracil
ring system. The oxygen being more electronegative than the carbon pulls the

7f

electrons

toward itself making the carbon electron deficient.
Ring closure then takes place by a nucleophilic attack of the carbon next to
the carbonyl of the uracil ring system to the second carbonyl of the 2,3-butanedione
molecule followed by a loss of water.

The reaction occurred in good yield (84%).

xxxv11
Figure 20. Synthesis of l,3,4,6-Tetramethyl-1,5,6,7-tetrahydropyrimido [4,5-c ]-5, 7-pyridazinedione

·

• I
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In this reaction, there was no formatio1{ of diacetyl-bis(3-methyluracil-6methylhyclrazone) as in the case of the condensation of compound XXXVI with glyoxal.
This result was expected since the two carbonyl groups of 2,3-butanedione

are less

reactive and more hindered than the ones in glyoxal.

l,6-Dimethyl-3,4-diphenyl-1,5,6,7-tetrahydropyrimido[

4,5-c ]-5,7-pyridazinedione

(XXXVIII).
6-(a-Methylhydrazino-3-methyluracil

(XXXVI) was condensed with benzil to

give compound XXXVIII. The reaction took place with more difficulty than the condensation of compound XXXVI wHh 2,3-butanedione.

This was expected because the

two carbonyl groups of benzil are deactivated by the two phenyl groups toward
nucleophilic substitution.

In order for the reaction to take place, a longer reflux time,

and a solvent with a higher boiling point than ethanol, namely, 2-methoxyethanol
...

used.

was

The reaction occurred in poor yield (25%) ..

xxxv1
Figure 21.

xxxVIII
Synthesis of l,6-Dimethyl-3,4-diphenyl-1,5,6,7-tetra
hydropyrimido[ 4,5-c ]-5,7-pyridazinedione
.J

.'

6-Hydrazino-3-mcthyluraci.l (XXXIX).,

Compound XXXIX was obtained by the nucleophilic displacement of the
chlorine atom in 6-chloro-3-methyluracil by hydrazine. Triethylamine was used to. ·trap
-.
~

hydrochloric acid formed in the reaction.

41

. H

. oyN.)I NH-NH2_
CH/NV
3,

X

• Q ....

'XXXlX

Figure 22. Preparation of 6-Hydrazino-3-methyluracil

3,4,6-Trimethyl-5,6, 7,8-tetrahydropyrimido [4,5-c ]-5, 7-pyridaz1nedione (XL).
6-Hydrazino-3-methyluracil

(XXXIX) was condensed with 2,3-1:iutanedione .

to give compound XL in a manner similar to the ring closure of compound XXXVI and
2,3-hutanedione.

'.l'he reaction took place in 97% yield.

C •

xxx1x

Figure 23. Synthesis of 3,4,6-Trimethyl-5,6,7,8-tetrahydropyrimido [4,5-c] -5,7-pyridazine<lione

42
6-Methyl-3,4-diphenyl-5,6, 7,8-tetrahydropyrimido[
6-Hydrazino-3-methyluracil

4,5-c ]-5, 7-pyridazinedione (XLI).

(XXXIX) was condense1 with.benzil to give com-

pound XLI in a manner similar to the ring closure of compound XXXVI and benzil. Th~
reaction

took place in low yi~ld (23%).

Re~rystallization

of compound

XLI was

attempted but was not successful, therefore it was washed with different solvents:
acid, dimethylformamide,
pound XLI was formed.
enough.

ethanol and water.

acetic

Infrared and nmr data showed,that

com-

The results from analysis showed that the sample was .riot pure

Further purification was not attempted.

I

. ·--'

~

,

XXXIX

:x:a
Figure 24. Synthesis of 6-Methyl-3,4-diphenyl-5,6,7,8-tetra·
hydropyrimido [4,5-c ]-5, 7-pyridazinedione
Glyoxal-bis-(6-hydrazone-3-methyluracil)
6-Hydrazino-3-methyluracil

(XLII).
(XXXIX) was reacted with 40% aqueous glyoxal

to give a compound which was postulated to be the dimer (XLII) similar to the findings
of Pfleiderer and Ferch (19).

When they carried out a similar reaction between -1,3-

43
dimethyl-4-hydrazinouracil and glyoxal, they obtai11ed a dimer, glyoxal-bis-(4-hydrazonc1,3-dimethyluracil).

The formation of compound XLIII was not observed.

xxx1x

XO[

XLIII
. Figure 25. Preparation of Glyoxal-bis-(6-hydrazone-3-rnethyluracil)
3-~leth_yl-6-({3-phenylhydrazino
)uracil (XLIV).
It vias earlier reported (21) that 6-chloro-3-methyluracil (X) and an excess of
pltcnylhydrazine reacted to give 6-(a-phenylhydrazine)-3-methyluracil
reaction was run using exactly the same conditions.

(XLIV).

The

Compound XLIY was obtained

whic!t structure was proved by cleavage of the hydrazino compound into 6-amino-3methyluracil (XLV) using both chemical reduction and catalytic hydrogenation.

.0yN'(H2
1-1

Sn/HCI

or

H/Raney
'

Ni

CH3Ny
0

XO[

• ;,,p

Figure 26.

Preparation ail<l Cleavage of 6-({3-Phenylhydrazino)-3-methyluracil

!
,'

The terminal nitrogen of phenylhydrazine

.44

1s more nucleophilic ·than the

nitrogen attached to the phenyl group, the lone pair of electrons of which is involved in
the resonance stabilization of the benzene ring.

Therefore, it is expected to obtain

6-(~-phenylhydrazino)-3-methyluracil (XLIV). Furthermore, all the reaction~ of phenylhydrazine reported in the literature showed

theterminal

nitrogen to be more nucleophilic.

Several attempts to cyclize compound XLIV with 2,3-butanedione failed, which was
expected as compound XLIV does not have a -NH2 group to react with the carbonyl
group of 2,3-butanedione.

6-:\Iethylamino-3-methyluracil (XLVI).
The preparation of compound XLVI has previously been reported (21) by
catalytic hydrog~nation of 6-(o:-methylhydrazino)-3-methyluracil

(XXXVI).

Another

method was used to prepare XLVI, starting with 6-chloro-3-methyluracil (X) and 40%
aqueous rnethylamine.

Compound XLVI was obtained in 44% yield.

H

oyJN
Cl
I
,

CH_..N
3

0

X
Figure 27. Preparation of 6-Methylamino-3-methyluracil

Attempted

Synthesis of 3,8-Dimcthyl-2,3,4,8-tetrahydropyrido[2,3-d]-2,4-pyrimidine-

dione (XL VII) (2,4-Dideazatoxoflavin).
Several attempts to convert 6-methylamino-3-methyluracil

(XLVI) into com- ·

pound XL VII by allowing compound XLVI to react with malonaldehyde bis-dimethyl
acetal following the method of Ridi, Checchi and Papini (26) under varying conditions
were not successful.

.·,
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x(vl
Figure 28. Attempted Synthesis of 2,4-Dideazatoxoflavin

3-:\Iethyl-6-n-propylaminouracil

(XLVIII).

Compound XL VIII was obtained by allowing 6-chloro-3-methyluracil (X) to
react with n-propylamine in a pressure bottle in which the chlorine atom on compound
X was replaced by the amino group.
Several attempts to convert 3-methyl-6-n-propylaminouracil
3-methyl-8-n-propyl-2,3,4,8- tetrah ydropyrido [ 2,3-d] -2,4-pyrimidinedione
3,5,7-trimethyl-8-n-propy

(XLVIII) into

(XLIX) and ·•

1-2,3,4,8- tetrahydropyrido[ 2,3-d] :2,5-pyrimidinedione

under varying conditions were unsuccessful.

(L)'

,,
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Figure 29. Preparation of 3-Methyl-8-n-propylaminouracil and Attempted
Synthesis of 8-n-Propyl Analogs of 2,4-Dideazatoxoflav:in

6-n-Butylamino-3-methyluracil (LI).
Method A.

.
Compound LI was prepared using the method of Pfleiderer and Ferch (19),
,

by refluxing a solution of 6-chloro-3-methyluracil (X) in n-butylamine and water during
one hour. The product did not precipitate from the solution when it was cooled. ··upon
evaporation of the solution a residue was left which crystallized with difficulty from an
ethanol-cyclohexane mixture.

The yield obtained was poor (28%).

'

'-.,:.
,
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:\[ethod B.
Compound

LI was prepared by heating 6-chloro-3-methyluracil

n-butylamine in a pressure bottle at ll0°
form.

for 3 hours. Upon cooling, crystals did not

The residue obtained after evaporation'. of the solution

ethanol.

(X) and

wascrys!allized

from

The yield obtained (48%) was better than that obtained by Method A.

X

\
TIIT
,,.

Figure 30. Preparation of 6-n-Butylamino-3-methyluracil and Attempted
SyHthesis of 8-n-Butyl Analogs of 2,4-Dideazatoxoflavin

,..
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6-Anilino-3-methylnracil (LIV).
This compound has been reported previously (21) and was prepared by the
nucleophilic displacement of the chlorine of compound X by aniline in a pressure bottle.
i'

.

Aniline is a poor nucleophile because its lone pair of electrons is involved ii:t the
resonance stabilization of the benzene ring and therefore is less available on the nitrogen
atom.

Synthesis

of 3,5,7-Trimethyl-8-phenyl-2,3,4,8:tetrahydropyrido

[ 2,3-d ]-2,4-pyrimidine-

dione (LV).
Compound LV was prepared by refluxing 6-anilino-3-methyluracil (LIV) and
2,4-pentanedione in the presence of phosphorus pentoxide.

Compound

LVcrystal~ized

from the brown mass previously washed ,vith boiling water with ethanol as a r_ecrystal-·
frzation solvent. Apparently compound LV was obtained because it was not soluble or
less rnlul,le in hot water containing phosphoric acid than compounds L and LIII, the
corresponding 8-alkyl analogs of compound LV '.

X

Figure 31. Synthesis of 3,5,7-Trimethyl-8-phenyl-2,3,4,8-tetrahydropyrido [ 2,3-d] -2,4-pyrimidinedione

-·
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6-Benzylamino-3-methyluracil (L VI).
•-

This compound has been previously reported (21) and was prepared by the
nucleophilic displacement of the chlorine of compound X by benzylamine in a pressure
bottle.

Attempted

Synthesis of 8-Benzyl-3,5,7-Trimethyl-2,3,4,8-tetrahydropyrido[2,3-d]-2,4-

pyrimidinedione

(XXXV).

It was expected to obtain compound XXXV by allowing 6-benzylamino-3methyluracil (L VI) to react with 2,4-pentanedione in the presence of phosphorus pentoxicle.

Instead 2-Hydroxy-3,5, 7-trimethyl-4(3.fJ)pyrido[2,3-d] pyrimidone (L VII) was

obtained in which the benzyl group was cleaved. This was confirmed by mnr results and
elemental analysis. A possible mecl1a11ism for the cleavage follows:

Figure 32. Suggested Mechanism for the Formation of 2-Hy<lroxy3,5, 7-trimethyl-4(3/J)pyrido [ 2,3-d] pyrimidinone
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3-Ethyl-2-ethylthio-6,hydroxy-4(3H)pyrimidinone

(L VIII).

An excess of diethylsulfate was added to a solution of 2-thioharbituric acid
(VII) in sodium hydroxide.

The exothermic reaction mixture waskept in an ice-bath.

Compound L VIII did not crystallize 'wheh the basic solution was acidified to pH 1-2
but f <?rmed a viscous oil. Crystallization occurred in anhydrous benzene.
Several attempts were made to chlorin~te compound LVIII with phosphorus
oxychloride and N,N-dimethylanilinc.

When the reaction mixture was poured on ice to

destroy the excess of phosphorus oxychloride, a viscous oil formed but no crystals were
obtained (LIX).

L..V
111

Figure 33. Synthesis of 3-Ethyl-2-cthylthio-6-hydroxy-4(3H)pyrimidione
·! .

•·

-,

· V.

CONCLUSION

The synthesis of 1;3,4,6-tetramethyl-l ,5,6, 7-tetrahydropyrimido [4,5-c ]-5, 7- .
pyridazinedione

(XXXVII)

and l,6-dimethyl-3,4~diphenyl-l,5,6,7-tetrahydropyrimido-

[4,5-c ]-5, 7-pyridazinedione (XXXVID) have been described starting with 6-(a-methyl.

'

hydrazino)-3-methyluracil (XXXVI) and the corresponding diketones, diacetyl and benzil
respectively.
The synthesis of 3,4,6-trimethyl-5,6,7,8-tetrahydropyrimido[

4,5-c ]-5,7-pyrid-

azincdione (XL) and of 6-methyl-3,4-diphenyl-5,6,7,8-tetrahydropyrimido[ 4,5-c ]-5,7.:
pyridazinedione (XLI) have been reported starting with 6-hydrazino-3-methyluracil
(XXXIX) and the corresponding diketones, diacetyl and benzil respectively.

An attempt to prepare 6-methyl-1,5,6, 7-tetrahydropyrimido [4,5-c ]-5, 7-pyridazinedione (XLIII) from 6-hydrazino-3-methyluracil and 40% aqueous glyoxal failed. .,
The ir an<l nmr data showed the formation of glyoxal-bis-6-hydrazone-3-methyluracil
(XLII).

The structure of 3-methyl-6-(/3-phenylhydrazino)uracil (XLIV) has.been proved·
by chemical and catalytic hydrogenation cleavage. Attempts to cyclize compound X1:,IY
with 2,3-butanedione were unsuccessful.
A new preparation

of 6-methylamino-3-methyluracil has been reported,

allowing 6-chloro-3-methyluracil and a 40% aqueous solution of methylamine to react
in a pressure bottle.

In the same way the synthesis of 3-methyl-6-n-propylami'nouraciL

(XL VIII) and 6-n-butylamino-3-methyluracil (LI) has been described starting with 6-

chloro-3-methyluracil and n-propylamine and n-butylamine respectively.

Attempted

cyclization of compound XLVIII and LI with malonaldehyde bis-dimethyi acetal and
2,4-pentanedione failed.

51

52

.

The synthesis of 3,5,7-trimethyl-8-phenyl-2,3,4,8-tetrahydropyrido[2,3-d]-2,4-

- .

P)Timidinedione (LY) was described starting with 6-anilino-3-methyluracil (LIV) and 2,4.

'

pentanedione in the presence of phosphorus pentoxide.

Using similar conditions, it was

expected that the condensation of 6(benzylamino-3-methyluracil (L VI) with 2,4-pentanedione would give 8-benzyl-3,5, 7-trimethyl-2,3,4,8-tetrahydropyrido

[ 2,3-d ]-2,4-pyrimid-

inedione (XXXV). Instead 2-hydroxy-3,5,7-trimethyl-4(3H)pyrido[2,3-d]

pyrimidinone

(LVII) was obtained due to the cleavage of the benzyl group under high heat and strong
acid conditions.
An attempt was made to prepare 6-chloro-3-ethyluracil from 2-thiobarbituric

acid using conditions similar to the preparation of 6-chloro-3-methylu~a:cil. The first
step, the conversion of 2-thiobarbituric acid into 3-ethyl~2-ethylthio-6-hydroxy-4(3H)pyrimidinone (L VIII) was successful. The second step, the conversion of compound
LVII into 6-chloro-3-ethyl-3-ethylthio-4(3H)pyrimidinone

(LIX) was not successful.

Sam pies of 4-deazatoxoflavin, 1,3,4,6-tetramethyl-l ,5,6, 7-tetrahydropyrimido[ 4,5-c ]-5,7-pyridazinedione

(XXXVII) and 3,5, 7-trimethyl-8-phenyl-2,3,4,8-tetrahydro-

pyrido [ 2,3-d ]-2,4-pyrimidinedione

(LV) were given to the pharmaceutical company,

Smith, Kline and French for biological testing.

It was found that none of the above •

compounds are biologically active. This would suggest that the presence of the nitrogen
in the 4-position of the toxoflavin ring system is essential for activity and not the one·
in the 1- or 2-position.

For example, it was mentioned earlier that the structure of

toxoflavin was very similar to the structure of the "flavins," in particular, flavin-adenine
dinucleoti<le and riboflavin which possess an oxidation-reduction system similar to that
of toxoflavin. Both flavin-adenine dinucleotide and riboflavin have the isolloxazine ring
system in which the nitrogen atoms in the 1 and 10 positions, corresponding to. the
nitrogei:i atoms in the 8 and 4 positions of toxoflavin, are involved in the oxidationreduction system.

This would lead to the conclusion that analogs of toxoflavin and

fervenulin to be synthesized should have the nitrogen in the 5-position in order to be
active.

It would be of interest to test the biological properties of 3,8-dimethyl-2,4-

53
(Ill, ..~ll)ptcridinedione(3,8-din~ethyl-lumazine

or 2-deazatoxoflavin)

synthesized

by·

{'

Pfleiderer and co,.;workers. If·thi,s co_n~pound has some biological activity, analogs of
2-deazatoxoflavin

.could be considered as potential antirnetabolites

or more specifically antitumor agents.

such as antibiotics

)

• i'1
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ABSTRACT

The synthesis of analogs of toxoflavin: 1,3,4,6-tetramethyl-l,5,6, 7-tetrahydro
pyr imido [ 4,5-c]-5,7 -pyridazinedione; l,6 -dimethyl-3,4-diphenyl-1,5,6,7-tetrahydro 
pyrimido[4,5-c]-5,7-pyridazinedione; 3,5,7 -trimethyl-8-phenyl-2,3,4,8-tctrahytlropyrido
[ 2,3-d]-2,4-pyrimidinedione are discussed. The synthesis of analogs of fcrvenulin:
,3,4,6-trimethyl-5,6,7,8-tetrahydropyrimido[ 4,5-c ]-5, 7-pyridazinedione; 6--mct liyl-3,4-di
phenyl-5,6, 7,8 -tetrahydropyrimido( 4,5-c]- 5, 7-p)Tidazinedione; 2-h yd ro xy-;3,5,7 -tri 
methyl-4(3H)pyrido[2,3-d]-2,4-pyrimidinone are discussed. Several intermediates have been prepared: 6 -methylamino-3-mcthylmacil by
a n_ew method; 6-n-propylamino-3-methyluracil: 6-n-butylamino-3-rnethyluracil and
3-ethyl-2-ethylthio-2-hydroxy-4(3H)pyrimidinone.
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